# B-Lymphocyte Stimulator (BLyS) To Treat Selective IgA Deficiency

> **NCT00024934** · PHASE1 · COMPLETED · sponsor: **National Cancer Institute (NCI)** · enrollment: 20 (—)

## Conditions studied

- IgA Deficiency

## Interventions

- **DRUG:** B-Lymphocyte Stimulator (BLyS)

## Key facts

- **NCT ID:** NCT00024934
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-10
- **Primary completion:** —
- **Final completion:** 2004-08
- **Target enrollment:** 20 (—)
- **Last updated:** 2016-09-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00024934

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00024934, "B-Lymphocyte Stimulator (BLyS) To Treat Selective IgA Deficiency". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00024934. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*